Developing global insight into RNA regulation

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 71, Issue , 2006, Pages 321-327

  Darnell, R B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOVA PROTEIN; RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; NERVE PROTEIN; NOVA ANTIGEN; TUMOR ANTIGEN;

ARTICLE; BIOCHEMISTRY; BIOINFORMATICS; GENE CONTROL; GENETICS; NERVE CELL; NEUROBIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MOUSE; NUCLEOTIDE SEQUENCE; REVIEW;

ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; HUMANS; MICE; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; NEURONS; RNA; RNA-BINDING PROTEINS;

EID: 34250688780     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2006.71.002     Document Type: Conference Paper

References (32)

1. Albert M.L. and Darnell R.B. 2004. Paraneoplastic neurological degenerations: Keys to tumour immunity. Nat. Rev. Cancer 4: 36.
2. Blencowe B.J. 2005. Splicing on the brain. Nat. Genet. 37: 796-. 2006. Alternative splicing: New insights from global analyses. Cell 126: 37.
3. Buckanovich R.J. and Darnell R.B. 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17: 3194.
4. Buckanovich R.J., Posner J.B., and Darnell R.B. 1993. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 11: 657.
5. Buckanovich R.J., Yang Y.Y., and Darnell R.B. 1996. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J. Neurosci. 16: 1114.
6. Darnell R.B. 1996. Onconeural antigens and the paraneoplastic neurologic disorders: At the intersection of cancer, immunity and the brain. Proc. Natl. Acad. Sci. 93: 4529.
7. -. 2002. RNA logic in time and space. Cell 110: 545.
8. Darnell R.B. and Posner J.B. 2003a. Observing the invisible: Successful tumor immunity in humans. Nat. Immunol. 4: 201.
9. -. 2003b. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 349: 1543.
10. -. 2006. Paraneoplastic syndromes affecting the nervous system. Semin. Oncol. 33: 270.
11. Dredge B.K. and Darnell R.B. 2003. Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol. Cell. Biol. 23: 4687.
12. Dredge B.K., Stefani G., Engelhard C.C., and Darnell R.B. 2005. Nova autoregulation reveals dual functions in neuronal splicing. EMBO J. 24: 1608.
13. Green R., Ellington A.D., Bartel D.P., and Szostak J.W. 1991. In vitro genetic analysis: Selection and amplification of rare functional nucleic acids. Methods 2: 75.
14. Huang C.S., Shi S.H., Ule J., Ruggiu M., Barker L.A., Darnell R.B., Jan Y.N., and Jan L.Y. 2005. Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition. Cell 123: 105.
15. Jensen K.B., Musunuru K., Lewis H.A., Burley S.K., and Darnell R.B. 2000a. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova KH3 domain. Proc. Natl. Acad. Sci. 97: 5740.
16. Jensen K.B., Dredge B.K., Stefani G., Zhong R., Buckanovich R.J., Okano H.J., Yang Y.Y., and Darnell R.B. 2000b. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25: 359.
17. Lewis H.A., Musunuru K., Jensen K.B., Edo C., Chen H., Darnell R.B., and Burley S.K. 2000. Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome. Cell 100: 323.
18. Lewis H.A., Chen H., Edo C., Buckanovich R.J., Yang Y.Y., Musunuru K., Zhong R., Darnell R.B., and Burley S.K. 1999. Crystal structures of Nova-1 and Nova-2 K-homology RNAbinding domains. Structure 7: 191.
19. Mili S. and Steitz J.A. 2004. Evidence for reassociation of RNAbinding proteins after cell lysis: Implications for the interpretation of immunoprecipitation analyses. RNA 10: 1692.
20. Musunuru K. and Darnell R.B. 2001. Paraneoplastic neurologic disease antigens-RNA-binding proteins and signaling proteins in neuronal degeneration. Annu. Rev. Neurosci. 24: 239.
21. -. 2004. Determination and augmentation of RNA sequence specificity of the Nova K-homology domains. Nucleic Acids Res. 32: 4852.
22. Newman L.S., McKeever M.O., Okano H.J., and Darnell R.B. 1995. β-NAP, a cerebellar degeneration antigen, is a neuronspecific vesicle coat protein. Cell 82: 773.
23. Rosenfeld M.G., Mermod J.J., Amara S.G., Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W., and Evans R.M. 1983. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304: 129.
24. Stamm S., Zhang M.Q., Marr T.G., and Helfman D.M. 1994. A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res. 9: 1515.
25. Szabo A., Dalmau J., Manley G., Rosenfeld M., Wong E., Henson J., Posner J.B., and Furneaux H.M. 1991. HuD, a paraneoplastic encephalomyelitis antigen contains RNAbinding domains and is homologous to Elav and sex lethal. Cell 67: 325.
26. Szostak J.W. and Ellington A.D. 1993. In vitro selection of functional RNA sequences. In The RNA world (ed. R.F. Gesteland and J.F. Atkins), p. 511. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
27. Ule J. and Darnell R.B. 2006. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr. Opin. Neurobiol. 16: 102.
28. Ule J., Jensen K., Mele A., and Darnell R.B. 2005a. CLIP: A method for identifying protein-RNA interaction sites in living cells. Methods 37: 376.
29. Ule J., Jensen K.B., Ruggiu M., Mele A., Ule A., and Darnell R.B. 2003. CLIP identifies Nova-regulated RNA networks in the brain. Science 302: 1212.
30. Ule J., Stefani G., Mele A., Ruggiu M., Wang X., Taneri B., Gaasterland T., Blencowe B.J., and Darnell R.B. 2006. An RNA map predicting Nova-dependent splicing regulation. Nature (in press).
31. Ule J., Ule A., Spencer J., Williams A., Hu J.S., Cline M., Wang H., Clark T., Fraser C., Ruggiu M., et al. 2005b. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37: 844.
32. Yang Y.Y.L., Yin G.L., and Darnell R.B. 1998. The neuronal RNA binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc. Natl. Acad. Sci. 95: 13254.